Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Michela Barca"'
1
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
Autor: Maria Teresa Ionta, Salvatore Ortu, Giuseppe Palmieri, Tito Sedda, Michela Barca, Panagiotis Paliogiannis, Giovanni Baldino, Annamaria Lanzillo, Giovanni Sanna, Luciano Virdis, Grazia Palomba, Mario Scartozzi, Mario Budroni, Antonio Pazzola, Francesca Capelli, Antonio Cossu
Publikováno v: Oncology Letters 12 (2016): 1415–1421. doi:10.3892/ol.2016.4798
info:cnr-pdr/source/autori:Palomba G.; Cossu A.; Paliogiannis P.; Pazzola A.; Baldino G.; Scartozzi M.; Ionta M.T.; Ortu S.; Capelli F.; Lanzillo A.; Sedda T.; Sanna G.; Barca M.; Virdis L.; Budroni M.; Palmieri G./titolo:Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma/doi:10.3892%2Fol.2016.4798/rivista:Oncology Letters/anno:2016/pagina_da:1415/pagina_a:1421/intervallo_pagine:1415–1421/volume:12
Oncology Letters (2015).
info:cnr-pdr/source/autori:Palomba G, Cossu A, Paliogiannis P, Pazzola A, Baldino G, Scartozzi M, Ionta MT, Ortu S, Capelli F, Lanzillo A, Sedda T, Sanna G, Barca M, Virdis L, Budroni M, Palmieri G/titolo:Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma/doi:/rivista:Oncology Letters/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
The presence of mutations in the KRAS gene is a predictor of a poor clinical response to EGFR-targeted agents in patients affected by colorectal cancer (CRC), but its significance as a global prognostic factor remains unclear. The aim of the present
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::413952f196cf9723e3c42eebb3680c6b
https://doi.org/10.3892/ol.2016.4798
Zobrazit plný text záznamu
2
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
Autor: Giuseppina Sarobba, Giulia Gramignano, Antonella Manca, Milena Casula, Tito Sedda, Salvatore Ortu, Panagiotis Paliogiannis, Efisio Defraia, Giuseppe Palmieri, Francesca Capelli, Carlo Putzu, Maria Colombino, Luciano Virdis, Antonio Cossu, Mario Scartozzi, Francesco Tanda, Antonio Pazzola, Maria Teresa Ionta, Giovanni Sanna, Giovanni Baldino, Michela Barca, Annamaria Lanzillo, Grazia Palomba, Valentina Doneddu, Mario Budroni
Publikováno v: Journal of Translational Medicine
Journal of translational medicine (Online) 14 (2016): 1–11. doi:10.1186/s12967-016-1053-z
info:cnr-pdr/source/autori:Palomba G.; Doneddu V.; Cossu A.; Paliogiannis P.; Manca A.; Casula M.; Colombino M.; Lanzillo A.; Defraia E.; Pazzola A.; Sanna G.; Putzu C.; Ortu S.; Scartozzi M.; Ionta M.T.; Baldino G.; Sarobba G.; Capelli F.; Sedda T.; Virdis L.; Barca M.; Gramignano G.; Budroni M.; Tanda F.; Palmieri G./titolo:Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: A population-based study/doi:10.1186%2Fs12967-016-1053-z/rivista:Journal of translational medicine (Online)/anno:2016/pagina_da:1/pagina_a:11/intervallo_pagine:1–11/volume:14
Background Activation of oncogenes downstream the EGFR gene contributes to colorectal tumorigenesis and determines the sensitivity to anti-EGFR treatments. The aim of this study was to evaluate the prognostic value of KRAS, BRAF, NRAS and PIK3CA muta
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35ea005c8e8b93b9379b7ca7475f26c7
https://pubmed.ncbi.nlm.nih.gov/27737711
Zobrazit plný text záznamu
3
CREAM study: Clinical correlation between immunotherapy-RElated clinical outcome and intestinal microbiote in metastatic patients
Autor: Emma Saba, S. Camera, Giorgio Astara, Aldo Manzin, Maura Murru, Paolo Piredda, Elena Massa, L. Orgiano, R. Mascia, Clelia Madeddu, Mariele Dessì, Tania Camboni, Vanessa Palmas, A. Cubeddu, Mario Scartozzi, Michela Barca, Elisabetta Pedditzi
Publikováno v: Journal of Clinical Oncology. 36:TPS215-TPS215
TPS215 Background: It's known that composition of intestinal flora can influence the development of inflammatory gastrointestinal diseases, even though the association of inflammation with specific intestinal microbes is still unknown, because the in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::230aa763ea18c0692c588d4d40c5d23c
https://doi.org/10.1200/jco.2018.36.5_suppl.tps215
Zobrazit plný text záznamu
4
Prognostic role of
Autor: Grazia, Palomba, Antonio, Cossu, Panagiotis, Paliogiannis, Antonio, Pazzola, Giovanni, Baldino, Mario, Scartozzi, Maria Teresa, Ionta, Salvatore, Ortu, Francesca, Capelli, Annamaria, Lanzillo, Tito, Sedda, Giovanni, Sanna, Michela, Barca, Luciano, Virdis, Mario, Budroni, Giuseppe, Palmieri
Publikováno v: Oncology Letters
The presence of mutations in the KRAS gene is a predictor of a poor clinical response to EGFR-targeted agents in patients affected by colorectal cancer (CRC), but its significance as a global prognostic factor remains unclear. The aim of the present
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::98b0bb836bcd6a2f94b0c2d4f30c1b59
https://pubmed.ncbi.nlm.nih.gov/27446446
Zobrazit plný text záznamu
5
Prolonged disease stability with trabectedin in two monorenal patients with retroperitoneal sarcoma
Autor: Francesca, Bruder, Daniela, Massa, Michela, Barca, Viviana, Contu, Mario, Airoldi, Alice, Crova
Publikováno v: Tumori. 100(3)
Soft tissue sarcomas constitute a heterogeneous group of tumors of mesenchymal origin: at present, more than 50 separate histological subtypes of soft tissue sarcoma have been listed. Although there have been advances in the understanding of these tu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d07db2d2accf6a0606eab0e068b3ef32
https://pubmed.ncbi.nlm.nih.gov/25076252
Zobrazit plný text záznamu
6
Long-term outcomes in stage IIIB breast cancer patients who achieved less than a pathological complete response (pCR) after primary chemotherapy
Autor: Luigi Minerba, Sergio Palmeri, Maria Teresa Ionta, B. Frau, Francesco Atzori, Monica Murgia, Maria Cristina Deidda, Michela Barca, Valeria Pusceddu, Bruno Massidda
Publikováno v: The oncologist. 14(11)
Learning Objectives After completing this course, the reader will be able to: Summarize the main risk factors for relapse in patients with T4 breast cancer after neoadjuvant chemotherapy.Evaluate the role of hormone receptors and HER-2 as determinant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::895c7f8745416c6a7c287b23972c5faf
https://pubmed.ncbi.nlm.nih.gov/19897535
Zobrazit plný text záznamu
8
Adding cisplatin to an anthracycline-based primary chemotherapy in triple-negative (TN) and non-triple negative (non-TN) T4 breast cancer patients (pts): Long-term outcomes
Autor: Michela Barca, Francesco Atzori, Bruno Massidda, Luigi Minerba, M. Murgia, M. T. Ionta, A. Trogu, F. Eltrudis, A. Coinu, B. Frau
Publikováno v: Journal of Clinical Oncology. 27:583-583
583 Background: Clinical data demonstrated that standard anthracycline-based chemotherapy may be less beneficial in TN. Conversely, there is extensive preclinical work showing that TN tumors are highly sensitive to platinum agents. Only a few studies
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::93ef502a21cc9d91535dd3c650abced4
https://doi.org/10.1200/jco.2009.27.15_suppl.583
Zobrazit plný text záznamu
9
Outcomes in double-negative (HER2/PR negative) LABC phenotype treated with cisplatin-based primary chemotherapy: Impact of intensified regimen
Autor: Maria Cristina Deidda, M. Murgia, M. T. Ionta, Bruno Massidda, A. Coinu, B. Frau, Luigi Minerba, Michela Barca, F. Eltrudis, Francesco Atzori
Publikováno v: Journal of Clinical Oncology. 25:11024-11024
11024 Background: It is widely assumed that HER2-negative and hormone receptors negative tumors (Triple-Negative as TN) are associated with poor outcome and would benefit from intensified chemotherapy and/or from specific EGFR-targeted therapies.Neve
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1d3fba77eddf607c8578c82ea31b9bc7
https://doi.org/10.1200/jco.2007.25.18_suppl.11024
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje